HER2 x CD3

(RG6194)

Breast

Phase I

A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

NCT03448042

Gastrointestinal

Phase I

A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

NCT03448042

Solid Tumor

Phase I

A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

NCT03448042